Hengkang Medical Group Co Ltd (SHE:002219) — Market Cap & Net Worth
Market Cap & Net Worth: Hengkang Medical Group Co Ltd (002219)
Hengkang Medical Group Co Ltd (SHE:002219) has a market capitalization of $1.15 Billion (CN¥7.82 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #8537 globally and #2224 in its home market, demonstrating a -4.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hengkang Medical Group Co Ltd's stock price CN¥2.31 by its total outstanding shares 3387381753 (3.39 Billion). Analyse how efficiently does Hengkang Medical Group Co Ltd generate cash to see how efficiently the company converts income to cash.
Hengkang Medical Group Co Ltd Market Cap History: 2016 to 2026
Hengkang Medical Group Co Ltd's market capitalization history from 2016 to 2026. Data shows change from $5.94 Billion to $1.15 Billion (-16.34% CAGR).
Hengkang Medical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hengkang Medical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.34x
Hengkang Medical Group Co Ltd's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
11.40x
Hengkang Medical Group Co Ltd's market cap is 11.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.94 Billion | $2.18 Billion | $403.63 Million | 2.73x | 14.71x |
| 2017 | $5.80 Billion | $3.40 Billion | $202.81 Million | 1.71x | 28.62x |
| 2018 | $1.71 Billion | $3.84 Billion | -$1.42 Billion | 0.44x | N/A |
| 2019 | $1.18 Billion | $3.68 Billion | -$2.52 Billion | 0.32x | N/A |
| 2020 | $877.35 Million | $2.81 Billion | -$52.24 Million | 0.31x | N/A |
| 2021 | $1.81 Billion | $3.02 Billion | -$371.43 Million | 0.60x | N/A |
| 2022 | $1.95 Billion | $3.16 Billion | $156.12 Million | 0.62x | 12.51x |
| 2023 | $1.50 Billion | $3.91 Billion | $28.97 Million | 0.38x | 51.84x |
| 2024 | $1.31 Billion | $3.80 Billion | $114.77 Million | 0.34x | 11.40x |
Competitor Companies of 002219 by Market Capitalization
Companies near Hengkang Medical Group Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Hengkang Medical Group Co Ltd by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Hengkang Medical Group Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Hengkang Medical Group Co Ltd's market cap moved from $5.94 Billion to $ 1.15 Billion, with a yearly change of -16.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.15 Billion | +8.45% |
| 2025 | CN¥1.06 Billion | -19.32% |
| 2024 | CN¥1.31 Billion | -12.87% |
| 2023 | CN¥1.50 Billion | -23.10% |
| 2022 | CN¥1.95 Billion | +7.65% |
| 2021 | CN¥1.81 Billion | +106.78% |
| 2020 | CN¥877.35 Million | -25.94% |
| 2019 | CN¥1.18 Billion | -30.52% |
| 2018 | CN¥1.71 Billion | -70.62% |
| 2017 | CN¥5.80 Billion | -2.25% |
| 2016 | CN¥5.94 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Hengkang Medical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.15 Billion USD |
| MoneyControl | $1.15 Billion USD |
| MarketWatch | $1.15 Billion USD |
| marketcap.company | $1.15 Billion USD |
| Reuters | $1.15 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more